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Picobirnaviruses 
in the Human 
Respiratory Tract
To the Editor: Picobirnaviruses 
(family Picobirnaviridae) are nonen-
veloped, double-stranded RNA virus-
es of vertebrates with a bisegmented 
genome. Segment 1 (2.2–2.7 kb) en-
codes the capsid protein, and segment 
2 (1.2–1.9 kb) encodes the RNA-
dependent RNA polymerase. On the 
basis of sequence diversity in segment 
2, picobirnaviruses are classifi ed into 
2 genogroups (1–4). Picobirnaviruses 
have been detected in fecal samples 
from humans with and without gastro-
enteritis; in patients co-infected with 
known enteric pathogens, including 
rotaviruses, caliciviruses, and astrovi-
ruses (1,4); and in a wide range of ani-
mals, such as pigs, calves, dogs, mon-
keys, and snakes. The pathogenicity 
of picobirnaviruses largely remains to 
be determined, but studies in immu-
nocompromised persons suggest that 
picobirnaviruses may be opportunistic 
enteric pathogens (5,6).
Recently, we identifi ed pico-
birnaviruses in the respiratory tract 
of pigs in Asia, and this identifi ca-
tion expanded the knowledge on the 
tropism and host range of picobirna-
viruses (7). No respiratory or other 
clinical signs were observed in these 
pigs at the time of sampling, making 
it unclear whether picobirnaviruses 
are indeed respiratory pathogens (7). 
To determine whether picobirnavi-
ruses could also be present in the hu-
man respiratory tract, we performed 
a diagnostic genogroup I picobirna-
virus PCR, with degenerated prim-
ers, that targeted the RNA-dependent 
RNA polymerase coding region 
(1,4,8) on 309 bronchoalveolar la-
vage specimens collected from 309 
patients with respiratory disease of 
unknown origin in the Netherlands 
during 2003–2006. (All study proce-
dures were performed in compliance 
with relevant laws and institutional 
guidelines and in accordance with the 
Declaration of Helsinki.) 
Samples from 3 patients were 
confi rmed by sequencing to be posi-
tive for genogroup I picobirnavi-
ruses. To determine genetic relation-
ships between human genogroup I 
picobirnaviruses from the respiratory 
tract and genogroup I picobirnavi-
ruses detected in wastewater and in 
human and porcine fecal samples, 
we constructed a phylogenetic tree 
on the basis of a ≈165-nt fragment 
of the RNA-dependent RNA poly-
merase gene as described (8) (Fig-
ure, Appendix, wwwnc.cdc.gov/
EID/article/18/9/12-0507-F1.htm). 
Before tree construction, 75 groups 
were created from the ≈300 available 
picobirnavirus sequences by using 
FastGroup II (10). Because the aver-
age pair-wise Jukes-Cantor distance 
was 0.46, a neighbor-joining tree was 
created by using the Jukes-Cantor 
model, with a bootstrap replication 
of 1,000 (Figure). One of the 3 geno-
group I picobirnavirus sequences 
found in this study, PBVI/Homo sapi-
ens/VS2000057/2003, showed <95% 
sequence identity with previously de-
scribed picobirnavirus sequences and 
is shown as a separate branch in the 
phylogenetic tree. The genogroup I 
picobirnavirus nucleotide sequences 
from the respiratory tracts of persons 
in the Netherlands showed 58% to 
97% similarity with each other. They 
belonged to different phylogenetic 
clades and did not group with other 
picobirnaviruses according to year of 
isolation or host species.
In conclusion, the identifi cation 
of new picobirnaviruses in respiratory 
tract samples from pigs (7) prompted 
us to look for the presence of pico-
birnaviruses in the respiratory tracts of 
humans. Genogroup I picobirnavirus-
es could be identifi ed in some of the 
bronchoalveolar lavage specimens ob-
tained from patients with unexplained 
respiratory disease in the Netherlands. 
This observation expands our knowl-
edge of picobirnaviruses in humans 
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and provides a clear example of how 
epidemiologic baseline information 
on virus host range and tropism in ani-
mals may provide indications for the 
presence of similar viruses in the same 
organ system of humans. To clarify 
the epidemiology and pathogenicity of 
picobirnaviruses in humans, addition-
al surveillance should be carried out in 
persons with and without respiratory 
and enteric disease.
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New Delhi 
Metallo-β-
Lactamase 
4–producing 
Escherichia coli 
in Cameroon
To the Editor: The metallo-
β-lactamase (MBL) group of 
enzymes inactivates many β-lactam 
antimicrobial drugs. First identifi ed 
from a Klebsiella pneumoniae strain 
recovered from a patient hospitalized 
in India, the New Delhi metallo-β-
lactamase-1 (NDM-1), particularly 
in Enterobacteriaceae, is now the 
focus of worldwide attention (1). 
Whereas India and Pakistan were 
considered as the main reservoirs of 
the blaNDM-1 gene (2) that produces 
this MBL, several NDM-1–producing 
Enterobacteriaceae isolates have been 
reported from the Balkan states and 
the Middle East, suggesting that those 
areas might be secondary reservoirs 
(2).
Since 2010, 3 NDM-1 point-
mutation variants have been described 
(3–5). The fi rst variant, NDM-2, was 
identifi ed from an Acinetobacter 
baumannii isolate collected from a 
patient transferred from a hospital in 
Egypt to Germany (4). Subsequently, 
a clonal dissemination of NDM-
2–producing A. baumanni was 
described in Israel (6). The second 
variant, NDM-4, which was identifi ed 
in Escherichia coli from a patient 
hospitalized in India, possessed 
a higher carbapenemase activity 
compared with NDM-1 (5). The most 
recent variant, NDM-5, was identifi ed 
in E. coli from a patient who had a 
history of hospitalization in India (3).
As recommended for the detection 
of carbapenemase producers (7), a 
rectal swab specimen was collected 
from a patient transferred from 
Cameroon to France. The E. coli strain 
FEK was isolated from the specimen. 
